Published in Cold Spring Harb Perspect Med on May 01, 2014
Genomic approaches for the discovery of genes mutated in inherited retinal degeneration. Cold Spring Harb Perspect Med (2014) 0.77
Penile transplantation: A long way to routine clinical practice. Pak J Med Sci (2017) 0.75
Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status. Chin Med J (Engl) (2016) 0.75
Recent advances in understanding and managing liver transplantation. F1000Res (2016) 0.75
Inhibitory effect of endostar on specific angiogenesis induced by human hepatocellular carcinoma. Gastroenterol Res Pract (2015) 0.75
Enlarged selection criteria for hepatocellular cancer: is the upper limit needed? Transl Gastroenterol Hepatol (2017) 0.75
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Infection in organ-transplant recipients. N Engl J Med (1998) 6.49
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl (2004) 2.65
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
National Institutes of Health Consensus Development Conference Statement: liver transplantation--June 20-23, 1983. Hepatology (1984) 2.50
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
The utility of marginal donors in liver transplantation. Liver Transpl (2003) 2.49
Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg (1990) 2.37
Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol (2004) 2.16
Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg (2013) 2.07
[Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir (1988) 2.02
Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology (2006) 1.93
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg (2011) 1.78
Liver transplantation for cholangiocarcinoma. Transpl Int (2010) 1.58
Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation. J Hepatol (2013) 1.56
Rapamycin: an anti-cancer immunosuppressant? Crit Rev Oncol Hematol (2005) 1.50
OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant (2013) 1.48
Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg (2012) 1.33
Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant (2008) 1.26
Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology (2009) 1.18
Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group. Transplantation (2009) 1.16
Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transplant (2012) 1.15
Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14
Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. HPB (Oxford) (2012) 1.03
Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review. Liver Transpl (2011) 1.01
Causes of death in autopsied liver transplantation patients. Mod Pathol (1998) 0.98
Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature. Liver Transpl (2010) 0.98
Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int (2009) 0.97
Candidate selection and organ allocation in liver transplantation. Semin Liver Dis (2009) 0.96
Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg (2007) 0.94
Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology (2012) 0.93
Bermuda Triangle for the liver: alcohol, obesity, and viral hepatitis. J Gastroenterol Hepatol (2013) 0.93
Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice. J Hepatol (2012) 0.91
The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus. Pediatr Diabetes (2011) 0.91
Split-cava technique: liver splitting for two adult recipients. Liver Transpl (2000) 0.90
Antiviral therapy for recurrent liver graft infection with hepatitis C virus. Cochrane Database Syst Rev (2010) 0.89
Piggy-back graft for liver transplantation. Cochrane Database Syst Rev (2011) 0.89
Origin and biology of the allogeneic response. Cold Spring Harb Perspect Med (2013) 0.87
CMV infection, diagnosis and antiviral strategies after liver transplantation. Transpl Int (2009) 0.87
Low toxicity immunosuppressive protocols in renal transplantation. Keio J Med (2004) 0.87
Adult liver transplantation in the United States. Am J Med Sci (2012) 0.86
Should length of sobriety be a major determinant in liver transplant selection? Curr Opin Organ Transplant (2013) 0.84
Combined liver and kidney transplantation. Curr Opin Organ Transplant (2010) 0.84
The importance of portal venous blood flow in ischemic-type biliary lesions after liver transplantation. Am J Transplant (2011) 0.84
Techniques of flushing and reperfusion for liver transplantation. Cochrane Database Syst Rev (2012) 0.84
Veno-venous bypass versus none for liver transplantation. Cochrane Database Syst Rev (2011) 0.84
Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trial. Transpl Int (2006) 0.83
Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation. Trials (2012) 0.83
Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation. Transplantation (2011) 0.83
Liver transplantation in the management of unresectable hepatoblastoma in children. Front Biosci (Elite Ed) (2012) 0.82
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl (2013) 0.81
Successful experiences of ABO-incompatible adult living donor liver transplantation in a single institute: no immunological failure in 10 consecutive cases. Transplant Proc (2013) 0.81
HIV-infected patients and liver transplantation: who, when and why. Curr HIV Res (2011) 0.80
Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study. BMC Nephrol (2010) 0.78
T-tube or No T-tube in Cadaveric Orthotopic Liver Transplantation: The Type of Tube Really Matters. Ann Surg (2015) 0.78
Transplantation for hepatocellular carcinoma: the North American experience. Recent Results Cancer Res (2013) 0.78
Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER). Clin Transplant (2013) 0.77
National Organ Transplant Act: Public Law 98-507. US Statut Large (1984) 0.77
The long reach of liver transplantation. Nat Med (2012) 0.77
Brain death and organ transplantation. J Forensic Med (1969) 0.76
The right posterior bile duct anatomy of the donor is important in biliary complications of the recipients after living-donor liver transplantation. Ann Surg (2013) 0.76
Liver transplantation in HIV-positive individuals: a new paradigm. Transplant Proc (2003) 0.76
Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut (2011) 1.84
Renal cell carcinoma metastases to the thyroid gland-8 cases reported. Thyroid (2007) 0.97
Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells. Biochim Biophys Acta (2010) 0.95
Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Cancer Sci (2011) 0.94
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Mol Cancer Ther (2008) 0.93
Socioeconomic status, severity of disease and level of family members' care in adult surgical intensive care patients: the prospective ECSSTASI study. Intensive Care Med (2012) 0.92
Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis. Mol Cancer Ther (2011) 0.90
Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer. Anticancer Res (2012) 0.90
Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha. Mol Cancer Res (2009) 0.90
Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO J (2011) 0.86
Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany. Int J Clin Exp Med (2010) 0.86
Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. Eur Arch Otorhinolaryngol (2011) 0.86
STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases. Neoplasia (2012) 0.85
Prospective evaluation of biliary reconstruction with duct-to-duct continuous suture in adult live donor liver transplantation. Langenbecks Arch Surg (2010) 0.81
Effectiveness of parathyroid-hormone measurement in detecting patients with multiple gland disease causing primary hyperparathyroidism. Langenbecks Arch Surg (2007) 0.80
Retrograde stapling of a free cervical jejunal interposition graft: a technical innovation and case report. BMC Surg (2014) 0.79
Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors. Anticancer Res (2012) 0.77
Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes? Atherosclerosis (2010) 0.77
Correspondence (letter to the editor): A new approach to early diagnosis? Dtsch Arztebl Int (2012) 0.75